Drug Shortage Report for PROQUAD

Last updated on 2024-07-29 History

Report ID	221447
Drug Identification Number	02399229
Brand name	PROQUAD
Common or Proper name	measles, mumps, rubella and varicella virus vaccine live Lyophilized powder for injection
Company Name	MERCK CANADA INC
Market Status	MARKETED
Active Ingredient(s)	VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s)	3.99Log10 PFU 3.00Log10 TCID50 4.30Log10 TCID50 3.00Log10 TCID50
Dosage form(s)	POWDER FOR SOLUTION
Route of administration	SUBCUTANEOUS SUBCUTANEOUS
Packaging sizes (GTIN) Click here to see a list of all reports for this drug.	(See additional packaging sizes)
Additional packaging sizes	10 X 1 DOSE VIAL
ATC code	J07BD
ATC description	VIRAL VACCINES
Reason for shortage	Demand increase for the drug.
Anticipated start date	2024-08-09
Actual start date
Estimated end date	2024-08-30
Actual end date	2024-07-29
Shortage status	Avoided shortage
Updated date	2024-07-29
Company comments	Remaining doses are reserved for the public immunization program
Health Canada comments
Tier 3 Status	No
Contact Address	16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7
Company contact information	1-800-567-2594 [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 39